AIM ImmunoTech Inc. (AIM UA) · 10+ Years of Financial Ratios

Profitability	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-18.36	-22.52	-18.94	-34.29	-36.23	-56.93	-58.3	-36	-49.93	-70.06	-54.36	-33.75	-31.28	-39.61	-96.75
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-426.13	-893.33	-547.83	-833.8	-722.67	-535.03	-1,101.5	-1,104.35	-170.71	-140.87	-537.86	-394.48	-529.63	100	79.21
EBITDA Margin (%)	-11,282.88	-11,560.74	-8,487.58	-9,228.64	-10,866.67	-9,115.23	-11,624.06	-13,588.04	-2,381.01	-2,893.19	-8,322.14	-8,763.19	-12,062.22	-13,948.23	-15,682.18
Operating Margin (%)	-11,949.55	-12,138.52	-8,878.88	-9,549.3	-11,444.67	-9,694.92	-12,518.8	-15,004.35	-2,612.36	-3,132.43	-8,887.86	-9,212.88	-12,636.3	-14,129.79	-15,800
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-9,730.37	-5,599.38	-8,147.42	-10,816.67	-8,857.87	-11,451.13	-8,154.35	-1,889.93	-2,677.66	-6,717.14	-8,834.36	-14,168.15	-13,790.78	-14,337.62
Profit Margin (%)	-6,468.47	-9,730.37	-5,599.38	-8,147.42	-10,816.67	-8,857.87	-11,451.13	-8,154.35	-1,889.93	-2,677.66	-6,717.14	-8,834.36	-14,168.15	-13,790.78	-14,337.62
Net Income to Common Margin (%)	-6,468.47	-9,730.37	-5,599.38	-8,147.42	-10,816.67	-8,857.87	-11,451.13	-8,154.35	-1,889.93	-2,677.66	-6,717.14	-8,834.36	-14,168.15	-13,790.78	-14,337.62
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	2	7	- -	- -	- -	- -	2	6	6	2	- -	1	1
ST Debt	- -	- -	2	7	- -	- -	- -	- -	- -	4	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	6	2	- -	1	- -
Total Debt/EBITDA	- -	-0.01	-0.13	-0.36	- -	- -	-6.47	- -	-0.18	-0.56	-0.55	-0.16	-0.01	-0.04	-0.02
Net Debt/EBITDA	4.64	0.19	0.08	-0.25	0.05	0.12	0.14	0.19	-0.04	-0.31	-0.23	2.68	1.97	1.38	0.17
Total Debt/EBIT	- -	-0.01	-0.13	-0.35	- -	- -	-6.01	- -	-0.16	-0.52	-0.51	-0.15	-0.01	-0.04	-0.02
Net Debt/EBIT	4.38	0.18	0.07	-0.24	0.05	0.11	0.13	0.17	-0.04	-0.29	-0.21	2.55	1.88	1.36	0.17
EBITDA to Interest Expense	- -	-1,418.82	-333.29	-819.04	-1,018.75	-1,632.45	-5,153.33	- -	-74.86	-21.15	-27.29	-21.26	-243.04	- -	- -
EBITDA-CapEx/Interest Expense	- -	-1,515.73	-382.95	-1,067.62	-1,090	-1,701.73	-5,316.67	- -	-75.35	-21.4	-28.14	-22.14	-252.49	- -	- -
EBIT to Interest Expense	- -	-1,489.73	-348.66	-847.5	-1,072.94	-1,736.27	-5,550	- -	-82.13	-22.9	-29.14	-22.35	-254.61	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	- -	- -	- -
Common Equity/Total Assets	-314.58	-421.03	-520.77	-422.76	-816.36	-942.82	-1,284.77	-1,592.1	-2,173.06	-2,301.01	-1,578.32	-529.44	-625.75	-939.78	-2,112.68
Long-Term Debt/Equity (%)	- -	0.21	0.26	0.12	0.08	- -	- -	- -	21.08	44.8	45.59	3.28	0.2	1.71	4.84
Long-Term Debt/Capital (%)	- -	-0.04	-0.04	-0.02	-0.01	- -	- -	- -	-0.6	-0.74	-1.91	-0.59	-0.03	-0.17	-0.12
Long-Term Debt/Total Assets (%)	- -	0.19	0.23	0.1	0.07	- -	- -	- -	12.92	16.74	29.53	3.11	0.19	1.63	2.55
Total Debt/Equity (%)	- -	0.34	4.85	16	0.19	0.09	- -	- -	21.08	114.51	47.46	3.73	0.26	2.18	7.02
Total Debt/Capital (%)	- -	-0.07	-0.82	-3.02	-0.02	-0.01	- -	- -	-0.6	-1.9	-1.99	-0.67	-0.04	-0.22	-0.18
Total Debt/Total Assets (%)	- -	0.3	4.24	12.4	0.18	0.07	- -	- -	12.92	42.8	30.74	3.54	0.26	2.07	3.7
Net Debt to Equity	-98.94	-6.36	-2.71	10.83	-2.74	-8.62	-10.38	-15.54	4.86	63.94	19.74	-62.44	-56.42	-70.33	-53.15
Net Debt/Capital (%)	22.12	1.33	0.45	-2.02	0.31	0.77	0.72	0.8	-0.14	-1.06	-0.82	10.14	8.18	6.66	1.32
EBITDA	-13	-16	-14	-20	-16	-18	-15	-13	-10	-11	-12	-14	-16	-20	-32
EBITDA-CapEx	-13	-17	-16	-26	-17	-19	-16	-13	-10	-11	-12	-15	-17	-20	-32
Operating Income (Loss)	-13	-16	-14	-20	-17	-19	-17	-14	-11	-11	-12	-15	-17	-20	-32

Liquidity	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	22.21	12.57	5.99	3.47	7.19	3.63	3.66	2.41	0.78	0.34	7.79	35.39	71.72	25.12	1.51
Current Ratio	22.33	12.95	6.27	3.54	7.33	3.72	4.34	2.85	1.29	0.72	9.27	36.58	74.61	26.69	1.68
Quick Ratio	22.21	12.57	5.99	3.47	7.19	3.63	3.66	2.41	0.79	0.55	8.52	36.41	74.16	26.35	1.65
CFO/Avg Current Liab	-4.34	-4.36	-2.56	-1.48	-2.23	-4.01	-4.67	-3.03	-3.09	-2.66	-2.83	-9.3	-15.74	-15.84	-4.25
Common Equity/Total Assets	-314.58	-421.03	-520.77	-422.76	-816.36	-942.82	-1,284.77	-1,592.1	-2,173.06	-2,301.01	-1,578.32	-529.44	-625.75	-939.78	-2,112.68
Long-Term Debt/Equity (%)	- -	0.21	0.26	0.12	0.08	- -	- -	- -	21.08	44.8	45.59	3.28	0.2	1.71	4.84
Long-Term Debt/Capital (%)	- -	-0.04	-0.04	-0.02	-0.01	- -	- -	- -	-0.6	-0.74	-1.91	-0.59	-0.03	-0.17	-0.12
Long-Term Debt/Total Assets (%)	- -	0.19	0.23	0.1	0.07	- -	- -	- -	12.92	16.74	29.53	3.11	0.19	1.63	2.55
Total Debt/Equity (%)	- -	0.34	4.85	16	0.19	0.09	- -	- -	21.08	114.51	47.46	3.73	0.26	2.18	7.02
Total Debt/Capital (%)	- -	-0.07	-0.82	-3.02	-0.02	-0.01	- -	- -	-0.6	-1.9	-1.99	-0.67	-0.04	-0.22	-0.18
Total Debt/Total Assets (%)	- -	0.3	4.24	12.4	0.18	0.07	- -	- -	12.92	42.8	30.74	3.54	0.26	2.07	3.7
CFO/Total Liabilities	-147.59	-207.33	-181.98	-101.05	-657.88	-314.79	-659.8	-218.67	-144.28	-122.71	-124	-315.14	-1,703.05	-797.43	-232.5
CFO/CapEx	-16.2	-11.15	-4.96	-2.2	-14.83	-18.33	-32.76	-16.26	-115.09	-83.78	-24.84	-17.43	-22.06	-59.44	- -
Altman's Z-Score	3.22	0.54	-4.86	-4.54	-3.21	-9.12	-15.86	-22.63	-33.92	-36.88	-24.44	6.6	25.4	-9.86	-37.85

Working Capital	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	36.42	2.83	1	4.18	0.16	0.09	0.24
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	10.02	128.79	363.7	87.33	2,264.35	4,293.28	1,514.21
Inventory Turnover	1.35	3.41	1.24	2.95	5.45	- -	2.41	1.67	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	270	107.1	294.66	123.87	67	- -	151.44	218.41	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	-0.27	1.62	0.77	0.81	0.46	0.75	1.78	-0.21	1.45	1.24	1.55	1.89	2.93	- -	0.01
Accounts Payable Turnover Days	-1,358.97	224.87	476.27	453.36	801.04	489	205.59	-1,758.03	251.15	293.36	235.43	193.59	124.74	- -	29,634.52
Cash Conversion Cycle	1,628.97	-117.76	-181.61	-329.49	-734.04	-489	-54.16	1,976.43	-241.13	-164.57	128.27	-106.26	2,139.61	- -	-28,120.32
Inventory to Cash Days	-270	-107.1	-294.66	-123.87	-67	- -	-151.44	-218.41	10.02	128.79	363.7	87.33	2,264.35	- -	1,514.21
Inventories	- -	1	1	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	1	1	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	1	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	1	- -	-1	- -	- -	-1	-1	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	77	65	27	43	42	46	20	17	11	9	6	78	47	15	23
- Cash & Cash Equivalents	58	3	3	2	1	2	2	2	1	- -	1	39	32	27	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	2	7	- -	- -	- -	- -	2	6	6	2	- -	1	1
Enterprise Value	19	29	-1	6	24	30	11	11	11	13	4	42	- -	-17	11
Total Capital	-204	-217	-225	-237	-260	-278	-293	-300	-307	-313	-320	-339	-360	-379	-408
Total Debt/Capital (%)	- -	-0.07	-0.82	-3.02	-0.02	-0.01	- -	- -	-0.6	-1.9	-1.99	-0.67	-0.04	-0.22	-0.18
Total Debt / EV	- -	0.01	-1.34	1.11	- -	- -	9.17	- -	0.17	0.44	1.56	0.05	-0.4	-0.05	0.07
EV/Sales	169.32	218.42	- -	30.25	159.8	150.08	81.97	117.72	24.2	36.56	29.23	257.67	- -	- -	54.08
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	63	66	27	37	42	42	19	15	9	8	2	59	46	15	22
Diluted Enterprise Value	5	63	26	42	41	40	17	13	10	14	8	23	15	-10	18
EV per Share	74.88	117.48	- -	20.45	75.14	76.6	23.24	19.69	14.16	12.11	0.39	1	- -	- -	0.22
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-13	-16	-14	-20	-16	-18	-15	-13	-10	-11	-12	-14	-16	-20	-32
TTM Operating Income	-13	-16	-14	-20	-17	-19	-17	-14	-11	-11	-12	-15	-17	-20	-32
TTM Cash Flow to Firm	- -	-12	-10	-13	-17	-14	-16	-7	-8	-10	-9	-10	-14	-16	-21
TTM Free Cash Flow to Firm	- -	-11	-8	-7	-16	-13	-16	-7	-8	-10	-8	-9	-13	-16	-21

Multiples	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-20.02	-6.1	-5.68	-3.72	-2.4	-3.57	-3.04	-4.01	-1.63	-1.47	-1.76	-4.74	-4.95	-1.86	-0.88
Price/Earnings High	-42.01	-8.07	-7.95	-7.32	-2.91	-5.29	-3.98	-6.25	-2.88	-2.52	-4.09	-8.4	-6.83	-2.79	-1.16
Price/Earnings Low	-4.87	-4.44	-2.7	-1.58	-1.96	-2.41	-1.14	-2.01	-1.04	-0.81	-0.15	-1.24	-2.28	-0.77	-0.54
Price/Book Value	-0.38	-0.3	-0.12	-0.18	-0.16	-0.16	-0.07	-0.06	-0.04	-0.03	-0.02	-0.23	-0.13	-0.04	-0.06
Price/Book Value Average	-0.85	-0.36	-0.23	-0.31	-0.15	-0.24	-0.17	-0.11	-0.05	-0.05	-0.14	-0.26	-0.27	-0.1	-0.06
Price/Book Value High	-1.79	-0.48	-0.32	-0.61	-0.18	-0.36	-0.22	-0.17	-0.09	-0.09	-0.33	-0.47	-0.37	-0.14	-0.08
Price/Book Value Low	-0.21	-0.26	-0.11	-0.13	-0.12	-0.16	-0.06	-0.06	-0.03	-0.03	-0.01	-0.07	-0.12	-0.04	-0.04
Price/Tangible Book Value	1.33	1.44	0.73	0.99	1.49	1.89	1.02	1.14	1.38	2.19	0.5	1.32	0.87	0.43	3.12
Price/Tangible Book Value Average	3.01	1.75	1.39	1.75	1.39	2.79	2.49	2.28	1.97	3.73	4.1	1.53	1.77	1.01	3.56
Price/Tangible Book Value High	6.32	2.32	1.94	3.43	1.68	4.14	3.26	3.55	3.48	6.41	9.53	2.71	2.44	1.52	4.68
Price/Tangible Book Value Low	0.73	1.28	0.66	0.74	1.13	1.88	0.93	1.14	1.26	2.06	0.35	0.4	0.81	0.42	2.17
Price/Sales	571.1	486.78	167.91	172.08	278.96	214.33	141.96	163.68	21.66	23.01	14.31	361.41	343.65	109.04	110.64
Price/Sales Average	1,294.99	593.5	318.01	303.4	259.09	316.13	348.3	326.82	30.83	39.24	118.12	418.59	701.07	256.41	126.23
Price/Sales High	2,717.67	784.82	444.96	596.41	314.89	468.85	456.07	509.53	54.49	67.41	274.79	742.35	967.84	385.06	165.96
Price/Sales Low	315.09	432.14	151.12	128.74	212.01	213.38	130.44	163.63	19.72	21.67	10.15	109.4	322.61	105.64	76.97
Price/Cash Flow	-6.82	-5.53	-2.68	-2.79	-2.48	-3.02	-1.18	-2.04	-1.19	-0.79	-0.22	-5.68	-3.32	-0.95	-1.05
Price/Cash Flow Average	-15.46	-6.74	-5.07	-4.92	-2.3	-4.46	-2.89	-4.07	-1.7	-1.35	-1.82	-6.58	-6.78	-2.24	-1.2
Price/Cash Flow High	-32.45	-8.91	-7.1	-9.67	-2.79	-6.61	-3.78	-6.35	-3	-2.33	-4.24	-11.67	-9.36	-3.37	-1.58
Price/Cash Flow Low	-3.76	-4.91	-2.41	-2.09	-1.88	-3.01	-1.08	-2.04	-1.09	-0.75	-0.16	-1.72	-3.12	-0.92	-0.73
Price/Free Cash Flow	-7.27	-6.07	-3.35	-5.11	-2.65	-3.2	-1.21	-2.17	-1.2	-0.8	-0.23	-6.03	-3.48	-0.97	-1.05
Price/Free Cash Flow Average	-16.48	-7.41	-6.35	-9.01	-2.47	-4.72	-2.98	-4.34	-1.71	-1.37	-1.9	-6.98	-7.1	-2.28	-1.2
Price/Free Cash Flow High	-34.58	-9.79	-8.89	-17.72	-3	-7	-3.9	-6.77	-3.02	-2.35	-4.42	-12.38	-9.8	-3.43	-1.58
Price/Free Cash Flow Low	-4.01	-5.39	-3.02	-3.82	-2.02	-3.18	-1.11	-2.17	-1.09	-0.76	-0.16	-1.82	-3.27	-0.94	-0.73
EV/Sales	169.32	218.42	- -	30.25	159.8	150.08	81.97	117.72	24.2	36.56	29.23	257.67	- -	- -	54.08
EV/Sales Average	1,047.09	566.02	311.42	381.13	255.74	330.98	349.55	336.23	36.29	58.64	377.42	336.43	479.44	75.62	107.62
EV/Sales High	2,772.16	755.09	438.88	726.83	311.89	496.1	462.63	538.83	63.39	89.72	824.11	765.04	749.91	204.36	147.76
EV/Sales Low	- -	406.57	143.88	175.07	208.37	219.89	120.96	155.27	23.57	39.24	69.56	- -	95.75	- -	57.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-9.28	-4.9	-3.67	-4.13	-2.35	-3.63	-3.01	-2.47	-1.52	-2.03	-4.54	-3.84	-3.97	-0.54	-0.69
EV/EBITDA High	-24.57	-6.53	-5.17	-7.88	-2.87	-5.44	-3.98	-3.97	-2.66	-3.1	-9.9	-8.73	-6.22	-1.47	-0.94
EV/EBITDA Low	1.25	-3.52	-1.7	-1.9	-1.92	-2.41	-1.04	-1.14	-0.99	-1.36	-0.84	0.83	-0.79	0.54	-0.37
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	-8.76	-4.66	-3.51	-3.99	-2.23	-3.41	-2.79	-2.24	-1.39	-1.87	-4.25	-3.65	-3.79	-0.54	-0.68
EV/EBIT High	-23.2	-6.22	-4.94	-7.61	-2.73	-5.12	-3.7	-3.59	-2.43	-2.86	-9.27	-8.3	-5.93	-1.45	-0.94
EV/EBIT Low	1.18	-3.35	-1.62	-1.83	-1.82	-2.27	-0.97	-1.03	-0.9	-1.25	-0.78	0.79	-0.76	0.53	-0.37
Last Price	306.24	258.72	105.6	137.28	132	118.27	42.24	30.36	14.52	8.41	0.55	1.85	0.98	0.32	0.46
High Price	1,457.3	417.13	279.84	475.79	149	258.72	135.7	94.51	36.52	24.64	10.56	3.8	2.76	1.13	0.69
Low Price	168.96	229.68	95.04	102.7	100.32	117.75	38.81	30.35	13.22	7.92	0.39	0.56	0.92	0.31	0.32
Enterprise Value	19	29	-1	6	24	30	11	11	11	13	4	42	- -	-17	11
Enterprise Value Average	116	76	50	81	38	65	46	31	16	22	53	55	65	11	22
Enterprise Value High	308	102	71	155	47	98	62	50	28	33	115	125	101	29	30
Enterprise Value Low	-16	55	23	37	31	43	16	14	10	14	10	-12	13	-11	12

Per Share Data Items	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	1	10	42	48	48	49
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	4	32	47	48	49
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	4	32	47	48	49
Revenue per Share	0.54	0.53	0.63	0.8	0.47	0.55	0.3	0.19	0.67	0.37	0.04	0.01	- -	- -	- -
EBITDA per Share	-60.5	-61.44	-53.38	-73.62	-51.42	-50.3	-34.59	-25.2	-15.96	-10.58	-3.2	-0.45	-0.34	-0.41	-0.65
Operating Income per Share	-64.08	-64.52	-55.84	-76.18	-54.15	-53.5	-37.25	-27.83	-17.51	-11.45	-3.42	-0.47	-0.36	-0.41	-0.66
Basic EPS, GAAP	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Basic EPS from Cont Ops	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Diluted EPS, GAAP	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Diluted EPS from Cont Ops	-34.69	-51.72	-35.21	-65	-51.18	-48.88	-34.07	-15.12	-12.67	-9.79	-2.58	-0.45	-0.4	-0.4	-0.6
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-44.91	-46.8	-39.44	-49.2	-53.32	-39.11	-35.91	-14.88	-12.18	-10.6	-2.49	-0.33	-0.29	-0.34	-0.44
Free Cash Flow per Basic Share	-47.69	-50.99	-47.39	-71.54	-56.91	-41.25	-37.01	-15.79	-12.29	-10.72	-2.59	-0.34	-0.31	-0.34	-0.44
Cash & Equivalents per Share	231.36	141.87	118.12	139.53	57.03	41.73	19	10.67	2.82	1.65	0.85	0.93	1.01	0.71	0.27
Book Value per Share	-814.57	-866.89	-881.73	-774.37	-815.52	-719.08	-624.69	-546.32	-413.29	-287.52	-31.54	-8.11	-7.52	-7.91	-8.34
Tangible Book Value per Share	230.54	179.89	144.37	138.62	88.46	62.55	41.6	26.59	10.5	3.85	1.11	1.4	1.13	0.75	0.15

AIM ImmunoTech Inc.

AIM UA

0.43

0.43